Neonatal Screening for Glucose-6-Phosphate Dehydrogenase Deficiency: Biochemical Versus Genetic Technologies

Seminars in Perinatology

Volumn 35, Issue 3, 2011, Pages 155-161

  Kaplan, Michael ^a,b   Hammerman, Cathy ^a,b  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Bilirubin encephalopathy; Glucose 6 phosphate dehydrogenase deficiency; Hemolysis; Neonatal hyperbilirubinemia; Neontal screening program

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE;

CLINICAL CHEMISTRY; COMPARATIVE EFFECTIVENESS; DNA POLYMORPHISM; DNA SCREENING; ENZYME ACTIVITY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; GENOTYPE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEALTH PROGRAM; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; KERNICTERUS; NEWBORN; NEWBORN SCREENING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVIEW; TANDEM MASS SPECTROMETRY;

DNA; FEMALE; GENOTYPE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HETEROZYGOTE; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; MALE; MICROSCOPY, FLUORESCENCE; NEONATAL SCREENING; POLYMERASE CHAIN REACTION;

EID: 79957933251     PISSN: 01460005     EISSN: 1558075X     Source Type: Journal    
DOI: 10.1053/j.semperi.2011.02.010     Document Type: Review

References (64)

1. Beutler E. G-6-PD deficiency. Blood 1994, 84:3613-3636.
2. Cappellini M.D., Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet 2008, 371:64-74.
3. Luzzatto L. Glucose 6-phosphate dehydrogenase deficiency: From genotype to phenotype. Haematologica 2006, 91:1303-1306.
4. Glucose-6-phosphate dehydrogenase deficiency. Bull World Health Org 1989, 67:601-611. WHO, Working Group.
5. Kaplan M., Hammerman C. Severe neonatal hyperbilirubinemia. A potential complication of glucose-6-phosphate dehydrogenase deficiency. Clin Perinatol 1998, 25:575-590.
6. Kaplan M., Hammerman C. Glucose-6-phosphate dehydrogenase deficiency: A hidden risk for kernicterus. Semin Perinatol 2004, 28:356-364.
7. Kaplan M., Hammerman C. Glucose-6-phosphate dehydrogenase deficiency: A potential source of severe neonatal hyperbilirubinaemia and kernicterus. Semin Neonatol 2002, 7:121-128.
8. Kaplan M., Hammerman C. Glucose-6-phosphate dehydrogenase deficiency and severe neonatal hyperbilirubinemia: A complexity of interactions between genes and environment. Semin Fetal Neonat Med 2010, 15:148-156.
9. Valaes T. Severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency: Pathogenesis and global epidemiology. Acta Paediatr Suppl 1994, 394:58-76.
10. Kaplan M., Muraca M., Vreman H.J., et al. Neonatal bilirubin production-conjugation imbalance: Effect of glucose-6-phosphate dehydrogenase deficiency and borderline prematurity. Arch Dis Child Fetal Neonat Ed 2005, 90:F123-F127.
11. Kaplan M., Abramov A. Neonatal hyperbilirubinemia associated with glucose-6-phosphate dehydrogenase deficiency in Sephardic-Jewish neonates: Incidence, severity, and the effect of phototherapy. Pediatrics 1992, 90:401-405.
12. Kaplan M., Herschel M., Hammerman C., et al. Hyperbilirubinemia among African American, glucose-6-phosphate dehydrogenase-deficient neonates. Pediatrics 2004, 114:e213-e219.
13. Nock M.L., Johnson E.M., Krugman R.R., et al. Implementation and analysis of a pilot in-hospital newborn screening program for glucose-6-phosphate dehydrogenase deficiency in the United States. J Perinatol 2010, 31:112-117.
14. Kaplan M., Vreman H.J., Hammerman C., et al. Contribution of haemolysis to jaundice in Sephardic Jewish glucose-6-phosphate dehydrogenase deficient neonates. Br J Haematol 1996, 93:822-827.
15. Kaplan M., Hammerman C., Renbaum P., et al. Differing pathogenesis of perinatal bilirubinemia in glucose-6-phosphate dehydrogenase-deficient versus-normal neonates. Pediatr Res 2001, 50:532-537.
16. Kaplan M., Herschel M., Hammerman C., et al. Neonatal hyperbilirubinemia in African American males: The importance of glucose-6-phosphate dehydrogenase deficiency. J Pediatr 2006, 149:83-88.
17. Kaplan M., Renbaum P., Levy-Lahad E., et al. Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: A dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl Acad Sci U S A 1997, 94:12128-12132.
18. Slusher T.M., Vreman H.J., McLaren D.W., et al. Glucose-6-phosphate dehydrogenase deficiency and carboxyhemoglobin concentrations associated with bilirubin-related morbidity and death in Nigerian infants. J Pediatr 1995, 126:102-108.
19. Ogunlesi T.A., Dedeke I.O., Adekanmbi A.F., et al. The incidence and outcome of bilirubin encephalopathy in Nigeria: A bi-centre study. Niger J Med 2007, 16:354-359.
20. Owa J.A., Ogunlesi T.A. Why we are still doing so many exchange blood transfusion for neonatal jaundice in Nigeria?. World J Pediatr 2009, 5:51-55.
21. Nair P.A., Al Khussiby S.M. Kernicterus and G6PD deficiency-a case series from Oman. J Trop Pediatr 2003, 49:74-77.
22. Rehman H., Khan M.A., Hameed A., et al. Erythrocyte glucose 6 phosphate dehydrogenase deficiency and neonatal jaundice. J Pak Med Assoc 1995, 45:259-260.
23. Wong H.B. Singapore kernicterus-The position in 1965. J Singapore Paediatr Soc 1965, 7:35-43.
24. Lai H.C., Lai M.P., Leung K.S. Glucose-6-phosphate dehydrogenase deficiency in Chinese. J Clin Pathol 1968, 21:44-47.
25. Johnson L., Bhutani V.K., Karp K., et al. Clinical report from the pilot USA Kernicterus Registry (1992 to 2004). J Perinatol 2009, 29(suppl 1):S25-S45.
26. AlOtaibi S.F., Blaser S., MacGregor D.L. Neurological complications of kernicterus. Can J Neurol Sci 2005, 32:311-315.
27. Sgro M., Campbell D., Shah V. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ 2006, 175:587-590.
28. Manning D., Todd P., Maxwell M., et al. Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and Ireland. Arch Dis Child Fetal Neonat Ed 2007, 92:F342-F346.
29. Padilla C.D., Therrell B.L. Newborn screening in the Asia Pacific region. J Inherit Metab Dis 2007, 30:490-506.
30. Joseph R., Ho L.Y., Gomez J.M., et al. Mass newborn screening for glucose-6-phosphate dehydrogenase deficiency in Singapore. Southeast Asian J Trop Med Public Health 1999, 30(suppl 2):70-71.
31. Missiou-Tsagaraki S. Screening for glucose-6-phosphate dehydrogenase deficiency as a preventive measure: Prevalence among 1,286,000 Greek newborn infants. J Pediatr 1991, 119:293-299.
32. Missiou-Tsagaraki S. Reply. J Pediatr 1992, 12:166.
33. Mallouh A.A., Imseeh G., Abu-Osba Y.K., et al. Screening for glucose-6-phosphate dehydrogenase deficiency can prevent severe neonatal jaundice. Ann Trop Paediatr 1992, 12:391-395.
34. Harris M.C., Bernbaum J.C., Polin J.R., et al. Developmental follow-up of breastfed term and near-term infants with marked hyperbilirubinemia. Pediatrics 2001, 107:1075-1080.
35. Hansen T.W., Nietsch L., Norman E., et al. Reversibility of acute intermediate phase bilirubin encephalopathy. Acta Paediatr 2009, 98:1689-1694.
36. Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or more weeks' gestation)-Summary. Paediatr Child Health 2007, 12:401-407. Fetus and Newborn Committee, Canadian Paediatric Society.
37. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004, 114:297-316. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia.
38. Lin Z., Fontaine J.M., Freer D.E., et al. Alternative DNA-based newborn screening for glucose-6-phosphate dehydrogenase deficiency. Mol Genet Metab 2005, 86:212-219.
39. Lyon M.F. Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature 1961, 190:372-373.
40. Beutler E., Yeh M., Fairbanks V.F. The normal human female as a mosaic of X-chromosome activity: studies using the gene for C-6-PD-deficiency as a marker. Proc Natl Acad Sci U S A 1962, 48:9-416.
41. May J., Meyer C.G., Grossterlinden L., et al. Red cell glucose-6-phosphate dehydrogenase status and pyruvate kinase activity in a Nigerian population. Trop Med Int Health 2000, 5:119-123.
42. Zangen S., Kidron D., Gelbart T., et al. Fatal kernicterus in a girl deficient in glucose-6-phosphate dehydrogenase: A paradigm of synergistic heterozygosity. J Pediatr 2009, 154:616-619.
43. Kaplan M., Beutler E., Vreman H.J., et al. Neonatal hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient heterozygotes. Pediatrics 1999, 104:68-74.
44. Kaplan M., Hammerman C., Vreman H.J., et al. Acute hemolysis and severe neonatal hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient heterozygotes. J Pediatr 2001, 139:137-140.
45. Herschel M., Ryan M., Gelbart T., et al. Hemolysis and hyperbilirubinemia in an African American neonate heterozygous for glucose-6-phosphate dehydrogenase deficiency. J Perinatol 2002, 22:577-579.
46. Beutler E., Blume K.G., Kaplan J.C., et al. International Committee for Standardization in Haematology: Recommended screening test for glucose-6-phosphate dehydrogenase (G-6-PD) deficiency. Br J Haematol 1979, 43:465-467.
47. Minucci A., Giardina B., Zuppi C., et al. Glucose-6-phosphate dehydrogenase laboratory assay: How, when, and why?. IUBMB Life 2009, 61:27-34.
48. Beutler E. A series of new screening procedures for pyruvate kinase deficiency, glucose-6-phosphate dehydrogenase deficiency, and glutathione reductase deficiency. Blood 1966, 28:553-562.
49. Wang F.L., Boo N.Y., Ainoon O., et al. Comparison of detection of glucose-6-phosphate dehydrogenase deficiency using fluorescent spot test, enzyme assay and molecular method for prediction of severe neonatal hyperbilirubinaemia. Singapore Med J 2009, 50:62-67.
50. Reclos G.J., Hatzidakis C.J., Schulpis K.H. Glucose-6-phosphate dehydrogenase deficiency neonatal screening: Preliminary evidence that a high percentage of partially deficient female neonates are missed during routine screening. J Med Screen 2000, 7:46-51.
51. Kaplan M., Leiter C., Hammerman C., et al. Comparison of commercial screening tests for glucose-6-phosphate dehydrogenase deficiency in the neonatal period. Clin Chem 1997, 43:1236-1237.
52. Van Noorden C.J., Vogels I.M. A sensitive cytochemical staining method for glucose-6-phosphate dehydrogenase activity in individual erythrocytes. II. Further improvements of the staining procedure and some observations with glucose-6-phosphate dehydrogenase deficiency. Br J Haematol 1985, 60:57-63.
53. Luzzatto L., Poggi V. Glucose-6-phosphate dehydrogenase deficiency. Nathan and Oski's Hematology of Infancy and Childhood 2009, 883-907. Saunders Elsevier, Philadelphia, PA. S.H. Orkin, D.E. Fisher, A.T. Look (Eds.).
54. Kaplan M., Hoyer J.D., Herschel M., et al. Glucose-6-phosphate dehydrogenase activity in term and near-term, male African American neonates. Clin Chim Acta 2005, 355:113-117.
55. Kaplan M., Leiter C., Hammerman C., et al. Enzymatic activity in glucose-6-phosphate dehydrogenase-normal and -deficient neonates measured with a commercial kit. Clin Chem 1995, 41:1665-1667.
56. Castro S.M., Weber R., Dadalt V., et al. Evaluation of glucose-6-phosphate dehydrogenase stability in blood samples under different collection and storage conditions. Clin Chem 2005, 51:1080-1081.
57. Keren R., Luan X., Friedman S., et al. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants. Pediatrics 2008, 121:e170-e179.
58. Kaplan M., Hammerman C. Neonatal hyperbilirubinemia: Don't let glucose-6-phosphate dehydrogenase deficiency off the hook. Pediatrics 2008, 122:216-217. author reply: 217-218.
59. Oppenheim A., Jury C.L., Rund D., et al. G6PD Mediterranean accounts for the high prevalence of G6PD deficiency in Kurdish Jews. Hum Genet 1993, 91:293-294.
60. Pollitt R.J. New technologies extend the scope of newborn blood-spot screening, but old problems remain unresolved. Acta Paediatr 2010, 99:1766-1772.
61. Carpenter K., Wiley V. Application of tandem mass spectrometry to biochemical genetics and newborn screening. Clin Chim Acta 2002, 322:1-10.
62. Howell R.R., Lloyd-Puryear M.A. From developing guidelines to implementing legislation: Actions of the US Advisory Committee on Heritable Disorders in Newborns and Children toward advancing and improving newborn screening. Semin Perinatol 2010, 34:121-124.
63. Issue devoted to newborn screening. Semin Perinatol 2010, 34. B.L. Therrel (Ed.).
64. Millington D.S., Sista R., Eckhardt A., et al. Digital microfluidics: A future technology in the newborn screening laboratory?. Semin Perinatol 2010, 34:163-169.